Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px
Document › Details

Bayer AG. (6/28/16). "Press Release: Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer [Not intended for U.S. and UK Media]". Berlin.

Region Region Barcelona
  Country Spain (España)
Organisations Organisation Bayer AG
  Group Bayer (Group)
  Organisation 2 University of Barcelona
Products Product regorafenib (BAY 73-4506)
  Product 2 clinical research
     


   
Record changed: 2016-07-18

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Bayer (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px




» top